H2020-JTI-IMI2-2020-22-single-stage

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH1 coordinated
• RIJKSUNIVERSITEIT GRONINGEN1 coordinated
• UEDIN1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• PFIZER2 projects · UK
• UOXF2 projects · UK
• CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH1 projects · AT
• RIJKSUNIVERSITEIT GRONINGEN1 projects · NL
• UEDIN1 projects · UK
• Leiden University Medical Center1 projects · NL
• UNIBO1 projects · IT
• ASTRAZENECA AB1 projects · SE
• AXXAM1 projects · IT
• BAYER AKTIENGESELLSCHAFT1 projects · DE

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• PFIZER2 projects · company
• CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH1 projects · company
• ASTRAZENECA AB1 projects · company
• AXXAM1 projects · sme
• BAYER AKTIENGESELLSCHAFT1 projects · company
• BIOTRIAL1 projects · sme
• BIOTRIAL BIOMETRICS1 projects · sme
• BIOTRIAL NEUROSCIENCE1 projects · sme
• BIOTRIAL RESEARCH1 projects · sme
• BII GMBH1 projects · company
• CONCENTRIS RESEARCH MANAGEMENT GMBH1 projects · sme
• GSKBIO1 projects · company

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 18 · avg 16.67

range 9 – 23 organisations

Country spread (sample)

12 countries

16–20 partner organisations (from median 18.0 in this call’s projects) · 12 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• PRISM 2€3,980,906
• PROMISE€3,744,375
• REsolution€1,000,000